Reneo Pharmaceuticals, Inc.
RPHM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $627 | $538 | $571 | $1,551 |
| - Cash | $111 | $28 | $20 | $125 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $518 | $511 | $552 | $1,427 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$54 | -$82 | -$54 | -$40 |
| % Margin | – | – | – | – |
| Net Income | $0 | -$77 | -$50 | -$40 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -2.3 | -2.04 | -2.19 |
| % Growth | 100% | -12.7% | 6.8% | – |
| Operating Cash Flow | -$51 | -$64 | -$47 | -$38 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$51 | -$64 | -$48 | -$38 |